Mephentermine Dependence: Emerging Trend of Substance Abuse and its Challenges
Dependence on Mephentermine, a widely used sympathomimetic pressor agent, is so far not extensively reported. In current report, we describe a male patient consuming extraordinary high amount of Mephentermine who developed psychosis which was successfully treated but relapsed after 5 months. In this background we also tried to highlight this trend of shift from more traditional drugs to new synthetic ones and look into the magnitude of the problem and challenges that lie ahead of us.
Gupta KK, Singh A, Singh G, Aggarwal S. Uncommon drug abuse: An anaesthetist dilemma. Anaesthesia Essays and Researches. 2015; 9(1):116–17. https://doi.org/10.4103/0259-1162.150191
Gehlawat P, Singh P, Gupta R, Arya S. Mephentermine dependence with psychosis. Gen Hosp Psychiatry. 2013; 35(6):681.e9–10. https://doi.org/10.1016/j.genhosppsych.2013.04.019 PMid:23759255
Sawant NS, Vispute CD. Mephentermine dependence with induced psychosis. German J Psychiatry. 2012; 15(2): 69–71.
De Sousa HF, De Oliveira MF, Lima MCD, De Oliveira JRD. Mephentermine dependence without psychosis: A Brazilian case report. Addiction 2010; 105(6):1129–30. https://doi.org/10.1111/j.1360-0443.2010.02935.x PMid:20456293
Mattoo SK, Parakh P. Mephentermine dependence: An emerging challenge. CNS Neuroscience and Therapeutics. 2012; 18:509–10. https://doi.org/10.1111/j.1755-5949.2012.00328.x PMid:22672305
Oliveira MF, De Sousa HF, Lima MCD, Oliveira JRM de. Mephentermine: rediscovering its biology and use, misuse and their implications. Rev Bras Psiquiatria Sao Paulo, Brazil. 1999; 33(1):98–9. https://doi.org/10.1590/S151644462011000100019
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.